Future Pharma’s Post

Thoughts on this? >> FDA gives accelerated approval to PBC drug at the center of Gilead’s $4.3B CymaBay deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #healthcare #biotech #productmarketing #pharmaceutical

Thoughts on this? >> FDA gives accelerated approval to PBC drug at the center of Gilead’s $4.3B CymaBay deal >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #biotech #healthcare #pharma #pharmaceutical #productmarketing

𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮 𝗡𝗲𝘄 𝗗𝗿𝘂𝗴 In the ever-evolving world of clinical treatments, a pharmaceutical industry leader faced a challenge: adapting its messaging to meet the changing needs of European physicians. 💊 We, at Jasper Colin, stepped in to help them create a strategic positioning for their new drug, ensuring it stood out in a competitive landscape. 💡 Our strategic positioning efforts gave the drug a competitive edge, making it a preferred choice among European physicians. 🏆 Read the full report to dive deeper into our methodology and discover how we transformed the drug's market positioning. 🔗 #JasperColin #DatatoDecision #StrategicPositioning #pharmaceuticalindustry #ClinicalTreatments #drugmanufacturing

Is #steptherapy becoming more common? We used the SPEC Database to examine commercial health plan coverage of 187 specialty drugs from 2017-2022 Plans included step therapy in roughly 1/3 more decisions in 2022 than they did in 2017 (36% vs 27%) Peter Neumann Molly Beinfeld Health Affairs Rochelle Henderson National Pharmaceutical Council #SPECDatabase #SpecialtyDrug #healthaccess #managedcare

Several states are considering or have enacted legislation to create #prescriptiondrug affordability boards (PDABs), some of which have the authority to set upper payment limits (UPLs) on drugs. In a February 27 webinar, @Michael Kolber, @Jonathan DiBello and industry thought leaders will examine the current PDAB landscape, how UPLs might be implemented, and the ways UPLs could impact the #pharmaceutical supply chain. Learn more and register here: 

Did you attend FCEPharma in Brazil? We're sharing our most important takeaways from what was an informative and exciting conference. Check them out in our latest blog. #brazilpharma #pharma #digitaltransformation #qualitymanagement https://lnkd.in/g64q5Ss3

Early, strategic launch planning is crucial for commercial success. Factors like market dynamics, clinical readouts, organizational scale, and unmet needs should guide this process. A data-driven approach ensures precision in roadmap development, focusing efforts where needed and capitalizing on ROI impact.

Launching a treatment demands precision at every step. Discover how our comprehensive approach in @Inizio Launch Elevate simplifies the complex journey. #Inizio #ReimagineHealth #ConnectedCapabilities  

Continuous improvement

How to best learn where your industry and business is heading? I continue to believe that a meaningful conversation with people outside your organization is critical. Thank you fellow panelists, McKinsey and The Digital Health Society for having me! Great and honest talk about where digital health is heading, “what to do and what not to do with Pharma”, and “should I build or partner”.